A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety

• Status: Withdrawn
• Trial end date: 2009-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This primary purpose of this study is to determine if ATHX-105 phosphate causes weight loss over a 12-week period.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Athersys, Inc
• Collaborators: INC Research; Syneos Health

Criteria

Inclusion Criteria:

• Obese adults with a body mass index of 30-45 kg/m2

Exclusion Criteria:

• Pregnancy

• Diabetes

• Adults with serious or unstable current or past medical conditions